QSP Modeling of Fibrosis in Liver, Lung, and Heart

Authors: Siler SQ, Longo DM, Generaux GT
Keywords: fibrosis, heart, IPFsym, liver, lung, non-alcoholic steatohepatitis (NASH), pulmonary playlist, QSP modeling
Software: DILIsym®, IPFsym®, NAFLDsym®
Division: Quantitative Systems Pharmacology (QSP)

Abstract

DILIsym Services expert modelers Diane Longo, Grant Generaux, and Scott Q. Siler will describe the development and use of QSP models designed to support drug development for:
• NASH (non-alcoholic steatohepatitis)
• IPF (idiopathic pulmonary fibrosis)
• new QSP models of fibrosis for additional indications

Join us and learn how QSP modeling can inform and accelerate drug development of anti-fibrotic medications and more!